Tudor Investment Corp’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$624K Buy
+16,284
New +$527K ﹤0.01% 2674
2025
Q4
Sell
-10,761
Closed -$151K 4070
2025
Q3
$151K Sell
10,761
-15,504
-59% -$177K ﹤0.01% 3235
2025
Q2
$251K Buy
26,265
+14,172
+117% +$135K ﹤0.01% 2977
2025
Q1
$112K Sell
12,093
-3,484
-22% -$45.1K ﹤0.01% 2934
2024
Q4
$217K Sell
15,577
-10,769
-41% -$195K ﹤0.01% 2788
2024
Q3
$619K Buy
+26,346
New +$553K ﹤0.01% 1903

Other funds holding TYRA

Tudor Investment Corp's TYRA Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 16,284 shares worth $624K. The stake represents ﹤0.01% of the portfolio and ranks #2674 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in TYRA as recently as Q3 2025.

Tudor Investment Corp first reported a position in TYRA in Q3 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Tudor Investment Corp held 16,284 shares of Tyra Biosciences worth $624K as of Q1 2026.
  • Tyra Biosciences was a new Tudor Investment Corp position in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2674 holding.
  • Tudor Investment Corp first reported a position in Tyra Biosciences in Q3 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.